We are live on !
Find out more
First Manhattan Portfolio holdings
AUM
$39.2B
Turnover
13.59%
1-Year Est. Return
21.04%
First Manhattan is an investment management firm founded in 1964 by David Gottesman, and it works mainly for high net worth individuals. Most of the assets it manages are in stocks, which its portfolio managers pick with a cautious, value-oriented approach. The firm also advises private funds focused on the banking industry and on companies that earn most of their revenue in China, along with two ETFs.
This Fund
S&P 500
This Quarter Est. Return
+5.01%
1 Year Est. Return
+21.04%
3 Year Est. Return
+83.94%
5 Year Est. Return
+115.5%
10 Year Est. Return
+416.22%
AUM
$16.8B
AUM Growth
+$390M
(+2.4%)
Cap. Flow
-$426M
Cap. Flow % of AUM
Cap. Flow %
-2.53%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
1,521
New
87
Increased
199
Reduced
379
Closed
51
Avg Time Held
2.8
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
2.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
U-Haul Holding Co
UHAL
|
+$61.4M |
| 2 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$37.6M |
| 3 |
Tanger
SKT
|
+$17.9M |
| 4 |
ANI Pharmaceuticals
ANIP
|
+$15.6M |
| 5 |
Gilead Sciences
GILD
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$59.7M |
| 2 |
Abbott
ABT
|
+$58.4M |
| 3 |
Old Republic International
ORI
|
+$47.4M |
| 4 |
Enerpac Tool Group
EPAC
|
+$37.7M |
| 5 |
Brookfield
BN
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 37.01% |
| 2 | Healthcare | 12.79% |
| 3 | Industrials | 9.57% |
| 4 | Technology | 9.22% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.22T
| $3.65B | 21.68% |
14,605
-74
| -0.5% | -$18.6M |
2013 Q2
15 quarters
|
|
|
2
Brookfield
BN
$92.4B
| $586M | 3.48% |
45,057,416
-2,298,577
| -5% | -$29.1M |
2013 Q2
15 quarters
|
|
3
Microsoft
MSFT
$3.94T
| $515M | 3.06% |
7,821,356
-245,481
| -3% | -$15.7M |
2013 Q2
15 quarters
|
|
4
Apple
AAPL
$4.98T
| $514M | 3.05% |
14,305,328
-657,076
| -4% | -$21.6M |
2013 Q2
15 quarters
|
|
5
Berkshire Hathaway Class B
BRK.B
$1.22T
| $450M | 2.67% |
2,697,932
-76,647
| -3% | -$12.8M |
2013 Q2
15 quarters
|
|
6
Johnson & Johnson
JNJ
$665B
| $316M | 1.88% |
2,540,261
-48,048
| -2% | -$5.74M |
2013 Q2
15 quarters
|
|
7
Zimmer Biomet
ZBH
$20B
| $258M | 1.53% |
2,174,926
-152,567
| -7% | -$17.3M |
2013 Q2
15 quarters
|
|
8
Honeywell
HON
$69.7B
| $246M | 1.46% |
2,182,541
-130,927
| -6% | -$14.5M |
2013 Q2
15 quarters
|
|
9
Wells Fargo
WFC
$252B
| $235M | 1.4% |
4,229,914
-76,427
| -2% | -$4.34M |
2013 Q2
15 quarters
|
|
10
Danaher
DHR
$162B
| $234M | 1.39% |
3,084,026
-199,201
| -6% | -$14.8M |
2013 Q2
15 quarters
|
|
11
Comcast
CMCSA
$86.6B
| $230M | 1.36% |
6,108,250
-197,904
| -3% | -$7.34M |
2013 Q2
15 quarters
|
|
|
12
AB InBev
BUD
$165B
| $205M | 1.22% |
1,870,967
-555,238
| -23% | -$59.7M |
2013 Q2
15 quarters
|
|
|
13
Gilead Sciences
GILD
$207B
| $197M | 1.17% |
2,899,349
+215,359
| +8% | +$15.1M |
2013 Q2
15 quarters
|
|
14
CVS Health
CVS
$107B
| $195M | 1.16% |
2,487,157
-165,202
| -6% | -$13.2M |
2013 Q2
15 quarters
|
|
15
Philip Morris
PM
$308B
| $192M | 1.14% |
1,696,201
-1,496
| -0.1% | -$154K |
2013 Q2
15 quarters
|
|
16
Aramark
ARMK
$13.9B
| $181M | 1.07% |
6,797,354
-698,209
| -9% | -$17.8M |
2014 Q2
11 quarters
|
|
17
Pfizer
PFE
$168B
| $179M | 1.06% |
5,509,723
+59,412
| +1% | +$1.87M |
2013 Q2
15 quarters
|
|
18
Oracle
ORCL
$362B
| $153M | 0.91% |
3,426,011
+159,494
| +5% | +$6.64M |
2013 Q2
15 quarters
|
|
19
Newell Brands
NWL
$2.33B
| $142M | 0.84% |
3,009,466
-49,549
| -2% | -$2.35M |
2016 Q1
4 quarters
|
|
20
IBM
IBM
$232B
| $140M | 0.83% |
842,377
+27,308
| +3% | +$4.58M |
2013 Q2
15 quarters
|
|
21
3M
MMM
$95.5B
| $140M | 0.83% |
876,245
-7,335
| -0.8% | -$1.13M |
2013 Q2
15 quarters
|
|
22
American International
AIG
$40.3B
| $118M | 0.7% |
1,893,188
-221,953
| -10% | -$14.3M |
2013 Q2
15 quarters
|
|
23
Coty
COTY
$3.57B
| $117M | 0.7% |
6,463,290
-260,376
| -4% | -$4.92M |
2016 Q4
1 quarter
|
|
24
GE Aerospace
GE
$335B
| $114M | 0.68% |
799,274
-1,141
| -0.1% | -$165K |
2013 Q2
15 quarters
|
|
25
Service Corp International
SCI
$10B
| $113M | 0.67% |
3,647,875
-277,128
| -7% | -$8.34M |
2015 Q1
8 quarters
|
|
Similar funds
First Manhattan's Q1 2017 Portfolio in Review
As of Q1 2017, First Manhattan held 1,521 positions worth $16.8B, up 2.4% from $16.4B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
First Manhattan's Q1 2017 filing shows 87 new, 199 increased, 379 reduced and 51 closed positions. Its largest new stake was ANI Pharmaceuticals: 278,095 shares worth $13.8M. The largest sale was AB InBev, an estimated $59.7M.
By sector, the portfolio is most concentrated in Financials at 37% of assets, down from 38% a quarter earlier, followed by Healthcare and Industrials.
- First Manhattan's largest Q1 2017 buy was ANI Pharmaceuticals: 278,095 shares worth $13.8M.
- First Manhattan added most to U-Haul Holding Co in Q1 2017, an estimated $61.4M increase.
- First Manhattan's biggest Q1 2017 reduction was AB InBev, cutting an estimated $59.7M.
- First Manhattan fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $5.91M.
- First Manhattan's ten largest holdings make up 44% of its $16.8B portfolio in Q1 2017.
- First Manhattan opened 87 new positions and closed 51 in Q1 2017.
- First Manhattan's portfolio value rose 2.4% quarter-over-quarter to $16.8B.
Based on First Manhattan's 13F filing for Q1 2017, filed 24 Apr 2017.